PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

Rhea-AI Summary

PacBio (NASDAQ: PACB) will report third quarter 2025 financial results and host a conference call on Wednesday, November 5, 2025 at 4:30 PM ET (1:30 PM PT). The call will be webcast and available at https://investor.pacificbiosciences.com/.

Listen live via internet or by phone: toll-free 1-888-349-0136 or international 1-412-317-0459. Dial-in participants should join 10 minutes early and request to join the "PacBio Q3 Earnings Call".

News Market Reaction

-3.16%

3 alerts

-3.16% News Effect

+13.2% Peak Tracked

-$18M Valuation Impact

$553M Market Cap

0.5x Rel. Volume

On the day this news was published, PACB declined 3.16%, reflecting a moderate negative market reaction. Argus tracked a peak move of +13.2% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $18M from the company's valuation, bringing the market cap to $553M at that time.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time.

The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.

Date: Wednesday, November 5, 2025, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459

If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q3 Earnings Call.”

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
Jim Gibson
ir@pacb.com

Media:
pr@pacb.com

FAQ

When will PacBio (PACB) report Q3 2025 results?

PacBio will report Q3 2025 results on Wednesday, November 5, 2025 and host the earnings call at 4:30 PM ET.

How can I listen to PacBio's Q3 2025 earnings call for PACB?

Listen via webcast at https://investor.pacificbiosciences.com/ or call toll-free 1-888-349-0136.

What time is PacBio's PACB Q3 2025 call in Pacific Time?

The call is at 1:30 PM PT on Wednesday, November 5, 2025.

What dial-in should international listeners use for the PACB Q3 call?

International callers can use 1-412-317-0459 and should join 10 minutes early.

Will PacBio provide a replay of the PACB Q3 2025 earnings call?

Yes; the webcast and replay will be available at https://investor.pacificbiosciences.com/.

What should I say when joining the phone line for PacBio's Q3 earnings call?

When dialing in, ask to join the "PacBio Q3 Earnings Call" and join about 10 minutes before the scheduled start.